Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
KZIA

Overview Financials Analysis Smart Money

Kazia Therapeutics Limited

KZIA · NASDAQ

Analyze with AI

Filings1

Total reported value$1.3K

Manager	Shares	Value	Change
Cordasco Financial Network	125	$1.3K	0.0%

SymbolKZIA

Market Cap$16.3M

IPO Date1999-01-06

CEOJohn Edwin Friend

Employees9

SectorHealthcare

IndustryBiotechnology

CountryAU

ExchangeNASDAQ Capital Market

Intelligent Bio Solutions Inc.

INBS

$5.38

+878.18%

Vision Marine Technologies Inc.

VMAR

$0.7525

+97.97%

B. Riley Financial, Inc.

RILY

$5.94

+59.54%

Cementos Pacasmayo S.A.A.

CPAC

$10.69

+52.93%

Everbright Digital Holding Limited Ordinary Shares

EDHL

$0.5575

+46.10%

Peers

Can-Fite BioPharma Ltd.

CANF · AMEX

$0.2876

+8.53%

CNS Pharmaceuticals, Inc.

CNSP · NASDAQ

$7.15

+0.85%

Silo Pharma, Inc.

SILO · NASDAQ

$0.4044

+0.40%

Soligenix, Inc.

SNGX · NASDAQ

$1.55

-0.32%

Biodexa Pharmaceuticals Plc

BDRX · NASDAQ

$5.67

+18.62%

Clearmind Medicine Inc.

CMND · NASDAQ

$2.62

-3.68%

InMed Pharmaceuticals Inc.

INM · NASDAQ

$1.31

+9.17%

GRI Bio, Inc.

GRI · NASDAQ

$0.4489

-5.49%

Oragenics, Inc.

OGEN · AMEX

$0.8255

-1.32%

Titan Pharmaceuticals, Inc.

TTNP · NASDAQ

$2.34

-11.36%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.